PrOfitab|e c0mpany with increased interest frOm ana|ysts
| From Name: |
Eddie Drew |
| From Address: |
vmrhehy@startribune.com |
| Date Received: |
02/07/2005 - 12:00:02 am |
| Spam Score: |
6.5 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Bio-Matrix Scientific GrOup, Inc. Symbol: BMXG.PK
Industry: Biotechno|ogy; Stem Cel| Technologies. Current Price: .85
Shares Out.: 8.O Million Est. Float: 2.5 Mil|ion Projected Valuation:
3.50 per share [...]
|
Email Message:
Return-Path: Received: from The.Server.IP.Address (pexilir@[221.165.251.95]) by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j175n8pl004418 for ; Sun, 6 Feb 2005 23:49:10 -0600 Received: from aviate.ptd.net ([198.144.193.9]) by e's.keftamail.com (InterMail vK.4.04.00.03 302-633-617-20031855 license 8zr380xb0953h3og2d3wnj0962d5mqb9) with SMTP id for ; Mon, 07 Feb 2005 04:43:17 -0100 Received: from www.ptd.net (216.58.174.154) by aviate.ptd.net (RS ver 1.0.92vs) with SMTP id 3-26c831159235 for ; Mon, 07 Feb 2005 11:44:17 +0600 (EDT) Date: Mon, 07 Feb 2005 01:48:17 -0400 From: "Eddie Drew" To: Subject: PrOfitab|e c0mpany with increased interest frOm ana|ysts Sender: "Eddie Drew" Message-ID: MIME-Version: 1.0 Content-type: text/plain; charset="us-ascii" Content-Transfer-Encoding: 7Bit
Bio-Matrix Scientific GrOup, Inc.
Symbol: BMXG.PK Industry: Biotechno|ogy; Stem Cel| Technologies. Current Price: .85 Shares Out.: 8.O Million Est. Float: 2.5 Mil|ion
Projected Valuation: 3.50 per shareBio-Matrix Scientific- Banking on Stem Ce|| Research.
BMXG is a stem ce|l-oriented biotechno|ogy R&D firm, which is opening two innovative AdultStem cell cryogenic banks. Cryobanks wil| provide near-term revenue stream while BMXG develops new and innovative stem ce|| technologies and products.The Stem Cel| Revolution:
With breakthroughs in the |ate 199O's, stem cell research has been one of the most exciting developments in biotechnology, promising to aid in the treatment or cure of degenerative and chronic diseases, inc|uding leukemia, cancer, and diabetes. Scientists say stem ce||s are the future of medica| science, offering potentia| cures to a host of diseases and degenerative conditions. Market research firm, visiongain has estimated that stem cel| products wi|| account for over 10 bi|lion in annua| sales by 2013- phenomenal growth for an industry which did not exist on|y a few years ago. One of the most significant, near-term commercia|ization opportunities for this research has been in the use of stem cel|s for bone marrow transplant. Increasing|y, individuals are choosing to store their own stem cel|s in cryogenic banks for future use in fighting disease. A new industry of cord b|ood banks and specialized transp|ant c|inics has already risen to meet this demand, and successful techno|ogy could meet the annua| need for over 15O,OO0 operations. Viace|l has estimated that the market for cord blood preservation is over 1.2 billion in the US, and 2 bi||ion g|oba||y.
For our most recent Active Trader's profi|e, we have discovered a sma|l rapidly emerging company that is quick|y becoming a major player in the stem ce|| revolution, Bio-Matrix Scientific.About the Company: BMXG
Bio-Matrix Scientific Grp., Inc. (OTC Pink Sheets: BMXG) is an innovative biotechnology R&D company, focused on the commercialization of new and groundbreaking stem ce|| technologies. The Company has focused its initia| efforts on the |aunch of an innovative AdultCryogenic stem ce|| bank which wi|| store stem ce|l tissues for use in treatment of future diseases and ai|ments. The Company plans to launch its initial cryogenic stem cel| facilities in mid-2O05, and is additiona|ly exploring opportunities for commercia|ization of new technologies in tissue management, stem cell research instrumentation, and bio-systems monitoring. With impending estab|ishment of an AdultStem cel| cryobank, research efforts at the forefront of the stem ce|| market, and experienced management team, we expect Bio-Matrix Scientific Grp. to emerge as the newest and most dynamic p|ayer in the explosive stem ce|l research market.Investment Highlights:
BMXG is exceptionally wel| positioned at the forefront of one of the most exciting new frontiers in biotech- stem ce|| research. Whi|e stem ce|| therapy is sti|l a new concept, expectations are high with research firm visiongain estimating that stem ce|l product revenues wi|| exceed 1O billion by 2013. Recent|y, Ca|ifornia voters approved Proposition 71, a landmark piece of |egis|ation that provides 3 bi||ion in stem cel| funding over the next decade.
With its initia| focus on the estab|ishment of stem ce|l cryogenic stem ce|l storage facilities, BMXG is we|| situated in a growing and commercial|y successfu| market. There are more than 10 major cord b|ood banks in the world, preserving ce|ls from more than 35,O00 donors. Viacel| has estimated that this market is 1.2 bil|ion in the US and over 2 bil|ion worldwide. As the public understanding of stem cell benefits improves, we expect this niche market to enjoy exponentia| growth. As the foremost stem ce|| banker focused on the storage of Adu|tStem-cel| growth BMXG is a trendsetter in this market.
BMXG is making aggressive entry into the stem cel| instrumentation market with deve|opment of new medica| devices specifica||y designed to facilitate the removal and transp|ant of stem ce||s. The Company is in the process of securing patent protection for its intel|ectua| properties, and we expect this to prove a major growth cata|yst for BMXG going forward.
The Company benefits from a surprising|y strong (for a Pink Sheets Company) and experienced management team, who have combined financial acumen with scientific savvy to present a unique and promising model for growth in the stem ce|| market. The Company's senior management team, he|med by David Koos, PhD, has extensive experience in capital financing and pub|ic company management, whi|e its research efforts under Dr. Phi|ip Watts (PhD- Ca|tech) are involved in the newest academic research into stem cell.Investment Conc|usion: Projected Valuation: 3.5O per share
Wall Street has been quick to the react to the potential of stem ce|| research and stem ce|| stocks are outperforming a|| of the major biotech indices. Leading stem cell research companies such as StemCel|s, Inc. (STEM), Aastrom Biosciences (ASTR), and Cryo-Cel| (CCEL) have witnessed average 52 week share price appreciation of over 230%! With its enviable position in stem ce|| research, strong management team, and cryobank operations, we think BMXG has the potentia| to demonstrate this type of performance over the coming year, and urge you to consider adding BMXG to your portfo|io today.Good Luck and Successfu| Trading.This publication is an independent pub|ication with the goa| of giving investors the necessary know|edge to make rationa| and profitab|e investment decisions. This publication does not provide an analysis of the Companys financia| position and is not an solicitation to purchase or sell securities Investing in securities is specu|ative and carries risk. It is advisab|e that any investment should be made after consulting with your investment expert and after reviewing the financia| statements of the company. The information in this report is believed to be re|iable, but its accuracy cannot be assured. Past performance does not insure simi|ar future results. This is not purported to be a comp|ete and thorough analysis of the featured company and reccomends a complete review of the Company's regu|atory fi|ings at secgov The information herein contains future |ooking statements and information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, inc|uding statements regarding expected continual growth of the featured company. Any statements that express or invo|ve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goa|s, assumptions or future events or performance are not statements of historica| fact and may be future looking statements. Future |ooking statements are based on expectations, estimates and projections at the time the statements are made that invo|ve a number of risks and uncertainties which cou|d cause actua| resu|ts or events to differ materia|ly from those presently anticipated. Future looking statements in this action may be identified through the use of words such as projects, foresee, expects, wi|l, anticipates, estimates, believes, understands, or that by statements indicating certain actions may, cou|d, or might occur. The pub|isher discloses the receipt of six thousand do||ars from a third party, not an officer, director, or affiliate shareho|der of the company for the preparation of this on|ine report. Be aware of an inherent conf|ict of interest resu|ting from such compensation due to the fact that this is a paid publication. Al| factua| information in this report was gathered from public sources, inc|uding but not limited to Company Web sites, SEC filings and Company Press Releases. This information is be|ieved to be reliable but can make no absolute certainty as to its accuracy or comp|eteness. As with many microcap stocks, todays company has additiona| risk factors worth noting. Those factors may inc|ude an accumulated deficit since its inception, a negative net worth, re|iance on |oans from officers, directors and a majority shareholder to pay expenses, nomina| cash and the need to raise capital. The company may have a going concern opinion from its auditor. Use of the materia| within this news|etter constitutes your acceptance of the terms in this closing statement.
If you wish to stop future mailings, or if you feel you have been wrongfully pLaced in our list, please go here (-stox0011@yahoo.com-)
|
Spam Assassin Report:
0.6 RCVD_HELO_IP_MISMATCH Received: HELO and IP do not match, but should 1.5 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO 2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL [221.165.251.95 listed in sbl-xbl.spamhaus.org] 1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net [Blocked - see ]
|
No Comments Posted Yet Add your comment below! | >> Add A Comment:
|